InfraReDx Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:InfraReDx Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6508
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Infraredx Inc (Infraredx), a subsidiary of Nipro Corp, is a cardiovascular imaging solutions provider. The company offers Makoto Intravascular Imaging System, Dualpro IVUS and Dualpro IVUS NIRS. It offers intravascular imaging catheter. Infraredx operates travascular imaging catheter utilizing extended bandwidth IVUS technology. The company’s Dualpro IVUS provides crisper image of the vessel structure and one can identify the degree of stenosis, visualize and quantify plaque burden, determine the landing zone for a stent and assure proper stent deployment. It provides optimization of coronary stenting procedures and post-stenting management services. Infraredx is headquartered in Burlington, Massachusetts, the US.

InfraReDx Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InfraReDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InfraReDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InfraReDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InfraReDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
InfraReDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InfraReDx Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Nipro Invests US$25 Million In Infraredx 10
Partnerships 11
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 11
Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 12
Infraredx Enters Into Co-Development Agreement With Philips 13
Infraredx Enters Into Distribution Agreement With Nipro For TVC Imaging System 14
Equity Offering 15
Infraredx Withdraws IPO 15
Acquisition 16
Nipro to Acquire Infraredx 16
InfraReDx Inc – Key Competitors 17
InfraReDx Inc – Key Employees 18
InfraReDx Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
InfraReDx Inc, Medical Equipment, Key Facts 2
InfraReDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
InfraReDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InfraReDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InfraReDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InfraReDx Inc, Deals By Market, 2012 to YTD 2018 8
InfraReDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nipro Invests US$25 Million In Infraredx 10
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 11
Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 12
Infraredx Enters Into Co-Development Agreement With Philips 13
Infraredx Enters Into Distribution Agreement With Nipro For TVC Imaging System 14
Infraredx Withdraws IPO 15
Nipro to Acquire Infraredx 16
InfraReDx Inc, Key Competitors 17
InfraReDx Inc, Key Employees 18
InfraReDx Inc, Subsidiaries 19

List of Figures
InfraReDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
InfraReDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
InfraReDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
InfraReDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
InfraReDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InfraReDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
InfraReDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InfraReDx Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[InfraReDx Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kiewit Corporation:企業の戦略・SWOT・財務情報
    Kiewit Corporation - Strategy, SWOT and Corporate Finance Report Summary Kiewit Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Toppan Printing Co Ltd:企業のM&A・事業提携・投資動向
    Toppan Printing Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Toppan Printing Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • IVERIC bio Inc (ISEE):企業の財務・戦略的SWOT分析
    Summary IVERIC bio Inc (IVERIC bio) formerly known as Ophthotech Corp, is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt di …
  • Playtech PLC:企業のM&A・事業提携・投資動向
    Playtech PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Playtech PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Roadrunner Transportation Systems Inc.:企業のM&A・事業提携・投資動向
    Roadrunner Transportation Systems Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roadrunner Transportation Systems Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Kadimastem Ltd (KDST):企業の財務・戦略的SWOT分析
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Axpo Holding AG-エネルギー分野:企業M&A・提携分析
    Summary Axpo Holding AG (Axpo) is an electricity utility that produces, trades and sells electricity. It is wholly owned by the cantons of Northeastern Switzerland. The company covers the entire value chain from power generation and marketing of a wide range of products to power distribution. It gen …
  • Societe BIC (BB):企業の財務・戦略的SWOT分析
    Societe BIC (BB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Monogram Biosciences Inc:企業の戦略的SWOT分析
    Monogram Biosciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Alcami Corp:企業の戦略的SWOT分析
    Alcami Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Wacoal Holdings Corp (3591):企業の財務・戦略的SWOT分析
    Wacoal Holdings Corp (3591) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Roquette Freres SA:企業の戦略的SWOT分析
    Roquette Freres SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Belfius Bank Sa:企業の戦略・SWOT・財務分析
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ardelyx Inc (ARDX):製薬・医療:M&Aディール及び事業提携情報
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company provides product portfolio such as tenapanor, RDX227675, RDX98940 and RDX013, among others. Its products are used for hyperphosphatemia in …
  • GVK Power and Infrastructure Ltd (GVKPIL):企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Textron Systems Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Select Medical Holdings Corp (SEM):企業の財務・戦略的SWOT分析
    Summary Select Medical Holdings Corp (SMHC) is a healthcare service provider that offers outpatient rehabilitation services. The center provides long-term acute care services such as cardiac services, infectious disease treatment, medically complex treatment, neuro or post-trauma, pulmonary or venti …
  • Complexa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases. The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s mai …
  • Bank of the Philippine Islands:企業の戦略・SWOT・財務情報
    Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆